We came across a bullish thesis on argenx SE on Stock Analysis Compilation. In this article, we will summarize the bulls’ thesis on ARGX. argenx SE's share was trading at $661.83 as of August 8th. ARGX’s trailing and forward P/E were 33.68 and 48.78 respectively according to Yahoo Finance.
[caption id="attachment_575381" align="aligncenter" width="750"]Argenx SE is a biotechnology company focused on developing Vyvgart, a leading FcRn inhibitor for autoimmune diseases, positioning it for strong long-term growth despite recent sales setbacks....
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.